UroToday - BPH &amp; Male LUTS

Home

BPH & Male LUTS

UroToday's BPH & Male LUTS section is a repository of the clinical publications, clinical trials and investigative science pertaining to the diagnosis and treatment of bph and male LUTS. Also available are conference coverage for all timely bph and male LUTS science, audio podcasts and downloadable slides from UroToday's slide library.

Online Urology & Urologic Oncology Journal
Please read about the UroToday International Journal; We welcome submissions year round and are committed to providing fast-tracked, peer reviewed publication.
Kind regards,
Christian Gratzke, MD
Associate Section Editor BPH and Male LUTS
UroToday International Journal

Display

results per page

Results 91 - 100 of 322

<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Glomerulation Observed During Transurethral Resection of the Prostate for Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia is a Common Finding but No Predictor of Clinical Outcome - Abstract
Wednesday, 16 January 2008
Department of Urology, Furuya Hospital, Kitami, Japan
read more

Inflammation and Benign Prostatic Hyperplasia - Abstract
Monday, 14 January 2008
Department of Urology, Queen's University, Kingston, Ontario, Canada
read more

Comparing the Therapeutic Outcome of Different Alpha-Blocker Treatments for BPH in the Same Individuals - Abstract
Monday, 14 January 2008
Gulhane Military Medical Faculty, Istanbul, Uskudar, 34668, Turkey
read more

(Phenylpiperazinyl)Cyclohexylureas: Discovery of Alpha(1a/1d)-Selective Adrenergic Receptor Antagonists for the Treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS) - Abstract
Friday, 11 January 2008
Johnson & Johnson Pharmaceutical Research and Development L.L.C., PO Box 300, 1000 Route 202 South, Raritan, NJ 08869, USA
read more

Resiniferatoxin and Botulinum Toxin Type A for Treatment of Lower Urinary Tract Symptoms
Thursday, 10 January 2008
BERKELEY, CA (UroToday.com) - Resiniferatoxin (RTX) and botulinum toxin type A (BTX-A) have drawn increasing attention in recent years as potential treatments for lower urinary tract symptoms (luts), including overactive bladder (OAB).
read more

Update on the Use of Dutasteride in the Management of Benign Prostatic Hypertrophy - Abstract
Monday, 07 January 2008
Division of Urology, Southern Illinois University School of Medicine, Springfield, IL 62794-9665, USA
read more

Doxazosin in the Treatment of Benign Prostatic Hypertrophy: An Update - Abstract
Tuesday, 25 December 2007
Minneapolis Veterans Affairs Center for Chronic Disease Outcomes Research, the Cochrane Review Group in Prostate Diseases and Urologic Cancers, Veterans Affairs Medical Center, Minneapolis 55417, USA
read more

Characterizing TUNA((R)) Ablative Treatments of the Prostate for Benign Hyperplasia with Gadolinium-Enhanced Magnetic Resonance Imaging - Abstract
Monday, 24 December 2007
Department of Urology, Mayo Clinic, Rochester, Minnesota
read more

Efficacy and Safety of a Combination of Sabal and Urtica Extract in Lower Urinary Tract Symptoms-Long-Term Follow-Up of a Placebo-Controlled, Double-Blind, Multicenter Trial - Abstract
Monday, 17 December 2007
Institute of Urology, 3rd Parkovaya Street 51, 105425, Moscow, Russia
read more

Understanding Patient and Physician Perceptions of Benign Prostatic Hyperplasia in Europe: The Prostate Research on Behaviour and Education (PROBE) Survey - Abstract
Friday, 14 December 2007
Institute of Urology and Nephrology, University College London, London, UK
read more